Faringosept tablets for resorption 10mg, No. 20

• Symptomatic treatment of infectious and inflammatory diseases of the oral cavity and pharynx (tonsillitis, laryngitis, pharyngitis, gingivitis, stomatitis);

• prevention of oral infections during the perioperative period (tonsillectomy, tooth extraction);

• prevention of professional laryngitis.

Locally. The tablets should be resorbed until completely dissolved, 15-30 minutes after meals. After using the tablets for 3 hours, you should refrain from drinking and eating.

Adults - 4-5 table. (0.04-0.05 g) per day.

Children from 3 to 7 years old - 3 tables. (0.03 g) per day. The course of treatment is 3-4 days.

Lozenges are round, flat-cylindrical, beveled to the edge, brown with intact edges; the presence of light and dark inclusions is allowed.

1 tab.

ambazona monohydrate 10 mg

Excipients: sucrose - 729 mg, lactose monohydrate - 150 mg, cocoa powder - 50 mg, povidone K30 - 50 mg, vanillin - 1 mg, stearic acid - 10 mg.

Hypersensitivity to the drug.

pharmachologic effect

Antiseptic agent for topical use in ENT practice and dentistry. Has a bacteriostatic effect. Active against Streptococcus haemoliticus, Streptococcus viridans and Pneumococcus.

Side effect

Allergic reactions are possible.

Application during pregnancy and lactation

During pregnancy and during breastfeeding, it is used in cases where the expected benefit of therapy for the mother outweighs the possible risk to the fetus or infant.

Application for violations of liver function

There are no special caveats.

Application for impaired renal function

There are no special caveats.

Application in children

Used in children over 3 years old.

Use in elderly patients

There are no special caveats.

special instructions

After taking Ambazon, it is recommended to refrain from eating and drinking for 3 hours.